Leverage Factor
The Disease Control Priorities Project reports on the cost effectiveness of intervention.
Project | Cost | Real world outcome | Outcome estimates | Economic value in Western terms | Leverage Factor |
---|---|---|---|---|---|
Case finding and treatment | $15 | 1 DALY saved | - | $90,000 | 6,000 |
Eflornithine for second stage treatment | $20 | 1 DALY saved | Sub-Saharan Africa target population | $90,000 | 4,500 |
Melarsoprol for second stage treatment | $10 | 1 DALY saved | Sub-Saharan Africa target population | $90,000 | 9,000 |
We focus on identification and the primary stage of the disease, and do not incorporate the second stage treatment into the Leverage Factor.
Leverage Factor
6,000